These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38125685)
1. A Case Report of Follicular Lymphoma in a Crohn's Disease Patient Treated With Azathioprine. Kottavadakkeel N; Farzina R; Rajaram A; Mannath S; Sunil A Cureus; 2023 Dec; 15(12):e50839. PubMed ID: 38125685 [TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
3. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease. Sultan K; Korelitz BI; Present D; Katz S; Sunday S; Shapira I Inflamm Bowel Dis; 2012 Oct; 18(10):1855-8. PubMed ID: 22241664 [TBL] [Abstract][Full Text] [Related]
4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
5. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
6. Azathioprine: state of the art in inflammatory bowel disease. Sandborn WJ Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759 [TBL] [Abstract][Full Text] [Related]
7. A comprehensive review and update on Crohn's disease. Gajendran M; Loganathan P; Catinella AP; Hashash JG Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine. Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632 [TBL] [Abstract][Full Text] [Related]
9. Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study. Olén O; Smedby KE; Erichsen R; Pedersen L; Halfvarson J; Hallqvist-Everhov Å; Bryder N; ; Askling J; Ekbom A; Sachs MC; Sørensen HT; Ludvigsson JF Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3132-3142. PubMed ID: 37061104 [TBL] [Abstract][Full Text] [Related]
10. IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases. Meuwissen SG; Ewe K; Gassull MA; Geboes K; Jewell D; Pallone F; Rachmilewitz D; Rask-Madsen J; Riddell BH; Sandborn BJ; Schmuck ML Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):13-8. PubMed ID: 10656204 [TBL] [Abstract][Full Text] [Related]
11. Recent advances using immunomodulators for inflammatory bowel disease. Nielsen OH; Bjerrum JT; Herfarth H; Rogler G J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468 [TBL] [Abstract][Full Text] [Related]
12. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527 [TBL] [Abstract][Full Text] [Related]
13. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease. Lamers CB; Griffioen G; van Hogezand RA; Veenendaal RA Scand J Gastroenterol Suppl; 1999; 230():111-5. PubMed ID: 10499471 [TBL] [Abstract][Full Text] [Related]
14. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD. Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385 [TBL] [Abstract][Full Text] [Related]
15. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance. Park MS; Kim DH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH Dig Dis Sci; 2015 Jan; 60(1):195-204. PubMed ID: 25239495 [TBL] [Abstract][Full Text] [Related]
16. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review. Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001 [TBL] [Abstract][Full Text] [Related]
17. Diffuse large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis: a case report. Sedai H; Shrestha S; Chand V; Poddar E; Acharya S; Koirala D Ann Med Surg (Lond); 2023 May; 85(5):2059-2063. PubMed ID: 37229049 [TBL] [Abstract][Full Text] [Related]
18. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Gjuladin-Hellon T; Iheozor-Ejiofor Z; Gordon M; Akobeng AK Cochrane Database Syst Rev; 2019 Aug; 8(8):CD010233. PubMed ID: 31425621 [TBL] [Abstract][Full Text] [Related]
19. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Flasar MH; Johnson T; Roghmann MC; Cross RK Inflamm Bowel Dis; 2008 Jan; 14(1):13-9. PubMed ID: 17973305 [TBL] [Abstract][Full Text] [Related]